The $4.8 billion startup is being investigated by the Department of Justice over its controlled dangerous substances prescribing practices.
Aetna Cancels In-Network Contract With Mental Health Startup Cerebral
The $4.8 billion startup is being investigated by the Department of Justice over its controlled dangerous substances prescribing practices.